- Country: USA
- Summary: In Vitro Assessments of Antimicrobial Activity
- UST Ref No: 113005978
- Deadline: 10 Mar 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 75N93024R00024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
AMENDMENT ONE
The purpose of Amendment One is to:
1. Provide a cut-off date for submission of questions;2. Provide updated instructions for the Proposal Intent Response Sheet;3. Clarify submission instructions to eCPS; and4. Respond to questions received regarding this solicitation.
______________________________________________________________________
Introduction
The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. The NIAID, Division of Microbiology and Infectious Diseases (DMID), has a requirement to support in vitro testing assess the therapeutic potential of compounds to advance our understanding of infectious diseases as well as advance the development of therapeutics for infectious diseases.
Description
NIAID supports nearly all stages of the product development pipeline from in vitro therapeutic evaluation through advanced therapeutic and vaccine testing and manufacturing using multiple support services contracts. The current solicitation addresses a critical stage in this pipeline by providing an efficient means to assess the therapeutic potential of compounds through in vitro testing. The overarching goal of the In Vitro Assessments of Antimicrobial Activity program is to provide capability in a broad range of in vitro testing capabilities to assess promising candidate countermeasures against the more than 270 infectious agents and vectors that are within the purview of DMID.
In addition to meeting the needs of extramural researchers, it is anticipated that contracts resulting from this solicitation will provide crucial data to be used by NIAID par... - Documents:
Attachment-1-Packaging-and-Delivery-of-Proposals.pdf
Attachment-3-Base-IDIQ-Statement-of-Work.pdf
Attachment-4-Sample-Task-Order-A-01.pdf
Attachment-5-Sample-Task-Order-A-02.pdf
Attachment-6-Sample-Task-Order-B-01.pdf
Attachment-7-Sample-Task-Order-C-01.pdf
Attachment-8-Sample-Task-Order-D-01.pdf
Attachment-10-Technical-Proposal-Cost-Summary.pdf
Attachment-11-Summary-of-Related-Activities.pdf
Attachment-12-Additional-Technical-Proposal-Inst.pdf
Attachment-13-Additional-Business-Proposal-Instr.pdf
Attachment-14-Proposal-Summary-and-Data-Record.pdf
Attachment-15-HHS-Industry-User-Guide-for-Subcon.pdf
Attachment-17-Offeror-Points-of-Contact.pdf
Attachment-18-Disclosure-of-Lobbying-Activities.pdf
Attachment-21-Safety-and-Health-HHSAR-352.pdf
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINIn Vitro Assessments of Antimicrobial Activity - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for In Vitro Assessments of Antimicrobial Activity. This tender is published on USARFP under UST Ref No: 113005978 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-03-10.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
